NeuroMetrix Reports Expanding Media Exposure for Quell™ Wearable Pain Relief Technology

WALTHAM, Mass.--()--NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, reported that Quell, launched in June 2015, is receiving broad media attention.

Quell is an over-the-counter wearable pain relief device that utilizes patented non-invasive neurostimulation technology to provide pain relief. The device is designed for people with conditions such as diabetic nerve pain, low back and leg pain, fibromyalgia, and pain associated with osteoarthritis. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. Users of the device have the option of using their smart phone to track and personalize their pain therapy through the Quell Relief app, which is available in the Apple app store.

Many recent substantive reports, articles, blogs, and interviews have been published on Quell. Highlights include:

“We are pleased with the growing media attention,” said Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix. “Quell has the potential to improve the lives of many chronic pain sufferers. Enhanced media exposure is helping us deliver the benefits of Quell to an expanding user community.”

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. For more information, please visit www.NeuroMetrix.com.

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com